TAK

Dopo l'orario di chiusura: 16.29

Takeda Pharmaceutical Co Adr (TAK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Takeda Pharmaceutical Co Adr

Healthcare (1112)

@takedapharma

Prossima data di guadagno

Ultimi documenti SEC

TAK's Discussions on Twitter

Confronta TAK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TAK Takeda Pharmaceutical Co Adr	16.29	50.36B	29.63B	260.53M	5.51B	0.0788
ZTS Zoetis Inc	124.05	54.82B	9.40B	2.65B	2.24B	5.935
HLN Haleon Plc Adr	10.46	46.00B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.81	36.32B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	468.94	20.33B	3.08B	1.24B	1.07B	25.61

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-13	Ripresa	Morgan Stanley	Overweight
2025-04-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-03-16	Aggiornamento	BofA Securities	Neutral → Buy
2022-07-19	Aggiornamento	Cowen	Market Perform → Outperform
2021-10-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-04-19	Downgrade	JP Morgan	Overweight → Neutral
2019-11-01	Iniziato	Cowen	Market Perform
2019-08-15	Downgrade	Daiwa Securities	Outperform → Neutral

Mostra tutto

Takeda Pharmaceutical Co Adr Borsa (TAK) Ultime notizie

Takeda Pharmaceutical Co Adr Azioni (TAK) Dati Finanziari

Takeda Pharmaceutical Co Adr (TAK)

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Confronta TAK con altri titoli

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Takeda Pharmaceutical Co Adr Borsa (TAK) Ultime notizie

Takeda Pharmaceutical ADR: Defensive Pharma Giant Tests Investor Patience as Shares Drift Near Lows - AD HOC NEWS

ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Finviz

Amyloidosis Therapeutic Market to Worth Over US$ 6.37 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.

KROS Stock Surges 85.6% in a Year: More Upside Potential in 2026? - Finviz

Takeda Pharmaceutical ADR Sees IBD RS Rating Climb To 76 - Investor's Business Daily

Book value per share of Takeda Pharmaceutical Co. Ltd. Sponsored ADR – GETTEX:TKDA - TradingView — Track All Markets

The Truth About Takeda Pharmaceutical Co Ltd: Is This Pharma Giant a Hidden Power Play for Your Port - AD HOC NEWS

G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.

Ethic Inc. Buys 43,295 Shares of Takeda Pharmaceutical Co. $TAK - Defense World

Takeda Pharmaceutical (NYSE:TAK) Strengthens Position in Healthcare - Kalkine Media

Takeda Pharmaceutical Co Ltd (TAK) Bonds - GuruFocus

Takeda Pharmaceutical Co Ltd ADR Stock Price Today | NYSE: TAK Live - Investing.com

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - GlobeNewswire Inc.

Denali Enters Into a $275M Funding Deal With Royalty Pharma - Finviz

INNOVENT BIO Completes Introduction of Takeda, Raising ~HKD780M Net - AASTOCKS.com

TAK vs. DSNKY: Which Stock Is the Better Value Option? - MSN

Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Coca-Cola Upgraded, Boeing Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

ADR movements on the 11th: In yen terms, Kirin HD, Takeda Pharmaceutical, and Mitsui Metals showed gains. - 富途牛牛

Takeda Pharma ADR earnings beat by $278.84, revenue fell short of estimates - Investing.com Nigeria

CMBI Adds INNOVENT BIO (01801.HK) TP to $110.62 on Strategic Partnership with Takeda Pharmaceutical - AASTOCKS.com

BofAS Elevates INNOVENT BIO (01801.HK) TP to $113 as Co-op with Takeda Pharmaceutical Marks Major Step Towards Becoming Multinational Pharma Firm - AASTOCKS.com

CLSA Lifts INNOVENT BIO's TP to HKD120.1; Takeda Pharma Co-op Positive for Product Development - AASTOCKS.com

Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors - Placera.se

INNOVENT BIO Opens Up 10% on Shr Issuance to Takeda Pharma at ~30% Premium w/ Licensing Deal Worth USD11.4B - AASTOCKS.com

INNOVENT BIO Issues Shrs at ~30% Premium to Takeda Pharma w/ Licensing Deal Involving USD11.4B - AASTOCKS.com

Bank of America Upgraded, Allstate Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Walt Disney Upgraded, Southwest Airlines Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History - Yahoo

Pharma stocks in Asia fall as Trump announces 100% tariffs - Investing.com

5 Best High-Yield Dividend Stocks to Buy Now - The Motley Fool

Takeda Pharmaceutical Co Adr Azioni (TAK) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a TAK